Share Name |
Share Symbol |
Market |
Type |
|
USOTC:ALIOF |
OTCMarkets |
Common Stock |
|
Price Change |
% Change |
Share Price |
Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
Shares Traded |
Last Trade |
|
0.00 |
0.00% |
278.50 |
|
|
|
|
|
0.00 |
01:00:00 |
Oncothyreon Inc. (ONTY) in Focus: Stock Up 5.2% - Tale of the Tape
02/12/2013 1:44pm
Zacks
Oncothyreon Inc. (ONTY) was a big mover last session, as the company saw its shares rise a little over 5% on the day. This rise can be attributable to solid volume too with far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock is now up 14.04% in the past one-month time frame.
In the last 30 days, the company witnessed 2 upward and downward estimate revisions each while the Zacks Consensus Estimate has remained unchanged in the same period. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.
Oncothyreon currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Some better-ranked biopharmaceutical stocks include Heska Corporation (HSKA), Actelion Ltd. (ALIOF) and AMAG Pharmaceuticals, Inc. (AMAG). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ACTELION LTD (ALIOF): Get Free Report
AMAG PHARMA INC (AMAG): Free Stock Analysis Report
HESKA CORP (HSKA): Free Stock Analysis Report
ONCOTHYREON INC (ONTY): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
1 Year Chart
|
1 Month Chart
|